EUCTR2021-005043-71-DE进行中（未招募）1 期
A Phase 2, Comparative Randomised Trial to Evaluate the impact of reduced COVID-19 mRNA vaccination regimen on immunological responses and reactogenicity in paediatric subjects withprior SARS-CoV-2 immunity - Immunogenicity and reactogenicity of reduced COVID-19 mRNA vaccination regimen in children (CoVacc)
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1.Aged = 5 years to = 11 years old on day of signing the informed consent form.
- •2.In good health or stable clinical condition.
- •3.Legally Accepted Representative (LAR) has reviewed the subject information and signed the informed consent form on behalf of the subject and the subject has expressed willingness to participate.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 200
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Has previously received any investigational or licensed COVID-19 vaccine.
- •2. Has known congenital or acquired immune disorder or immunodeficiency that may interfere with vaccine response e.g. known infection with human immunodeficiency virus (HIV) with low CD4 count or other immunosuppression at time of signing informed consent form.
- •3. Has a history of autoimmune disease or an active autoimmune disease requiring therapeutic intervention (including systemic glucocorticoids), or findings that may have a significant effect on the target endpoints and which may therefore mask or inhibit the therapeutic effect under investigation as judged by the investigator.
- •4. Bleeding diathesis or condition associated with prolonged bleeding that would, in the opinion of the investigator, contraindicate intramuscular injection or venepuncture.
- •5. History of severe adverse reaction associated with a vaccine and/or severe allergic reaction (eg, anaphylaxis) to any component of the study intervention(s).
- •6. Receipt of medications intended to prevent COVID-19.
- •7. Uses drugs with significant interaction with the investigational product or has any contraindications as per the Summary of Product Characteristics.
- •8. Other medical or psychiatric condition or laboratory abnormality that may increase the risk of study participation or, in the investigator’s judgment, make the participant inappropriate for the study.
- •9. Has any kind of dependency on the principal investigator or member of the study team or LAR is employed by the principal investigator or within the same department as the PI or study team at the institution where the study is executed.
- •10. Is unable to report solicited adverse events.
研究者
相似试验
进行中（未招募）
1 期
Clinical Study Evaluating the immune responses and safety of single versus two dose COVID-19 mRNA Vaccination in children (CoVacc)Healthy volunteers (paediatric subjects) with prior SARS-CoV-2 infectionMedDRA version: 23.1Level: LLTClassification code 10084464Term: COVID-19 immunizationSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2021-005043-71-NOniversity Medical Center Utrecht200
进行中（未招募）
1 期
Immunogenicity and reactogenicity of reduced COVID-19 vaccination regimen in children (CoVacc).Healthy volunteers (paediatric subjects) with prior SARS-CoV-2 infectionMedDRA version: 23.1Level: LLTClassification code 10084464Term: COVID-19 immunizationSystem Organ Class: 100000004865EUCTR2021-005043-71-GRniversity Medical Center Utrecht200
进行中（未招募）
1 期
Clinical Study Evaluating the immune responses and safety of single versus two dose COVID-19 mRNA Vaccination in children (CoVacc)Healthy volunteers (paediatric subjects) with prior SARS-CoV-2 infectionMedDRA version: 23.1Level: LLTClassification code 10084464Term: COVID-19 immunizationSystem Organ Class: 100000004865EUCTR2021-005043-71-SEniversity Medical Center Utrecht200
进行中（未招募）
1 期
Clinical Study Evaluating the immune responses and safety of lower dose COVID-19 mRNA Vaccination in children (CoVacc)Healthy volunteers (paediatric subjects) with or without prior SARS-CoV-2 infectionMedDRA version: 23.1Level: LLTClassification code 10084464Term: COVID-19 immunizationSystem Organ Class: 100000004865EUCTR2021-005043-71-NLniversity Medical Center Utrecht400
招募中
2 期
A Phase 2, Comparative Randomised Trial to Evaluate the impact of reduced COVID-19 mRNA vaccination regimen on immunological responses and reactogenicity in paediatric subjects with prior SARS-CoV-2 immunityNL-OMON54453niversitair Medisch Centrum Utrecht50